Trial intelligence / Profile preview

Iguratimod vs Methotrexate in Rheumatoid Arthritis

CTR20132012Phase 4Active

Sponsor
Simcere Pharmaceutical Group
Start
Mar 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of iguratimod in rheumatoid arthritis (RA), sponsored by Simcere Pharmaceutical Group. Started Mar 2014; status: active.

02

Drugs

iguratimod
03

Conditions

rheumatoid arthritis (RA)

Beyond the preview

Go deeper on CTR20132012.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20132012.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call